| Name | Title | Contact Details |
|---|
The Place for Children with Autism provides a comprehensive approach to autism treatment that focuses on the highest quality therapy to enrich the lives of children with autism and their families across all communities. Utilizing one-to-one ABA therapy in a structured, center-based environment, our programs are designed with quality as the priority and support as the ongoing means to achieve it. We specialize in all developmental areas to help children build independence and school readiness skills to succeed. The Place for Children with Autism works with families from all economic backgrounds to find options that fit their needs.
Since 1983, Schulman has provided the research community with IRB review services of the highest quality. In establishing the IRB, our founders sought to promote clinical research by helping to safeguard the rights and welfare of clinical research subjects. Schulman’s team of dedicated professionals seeks to provide timely, quality services based on the foundation of respect for persons, beneficence and justice. Through continuous quality improvement and rigorous training on human subject protection, Schulman provides thorough, ethical, responsive and thoughtful review of research studies. By combining impeccable review standards, savvy industry insight, responsive customer service and innovative technological solutions, Schulman creates a review experience that goes beyond the expected. We look forward to continued collaboration with our colleagues in North America and around the world as we uphold our mission to protect the rights and welfare of clinical research subjects.
Joint Commission Resources is a Oak Brook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pleasantview Industries Inc is a Santa Clarita, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NUCATS provides scientists with consultative resources and expertise in order to accelerate how quickly transformative scientific discoveries make their way to patients and the community. It is our goal to continually increase the quality, safety, efficiency and speed of innovative clinical and translational research.